|
|
||||||||
Clinic of Internal Medicine I, Friedrich-Schiller-University, Erlanger Allee 101, Jena, 07740 Germany
(Email: christian.jung{at}med.uni-jena.de).
We read with great interest the article by Thiagarajan and colleagues [1]. The authors presented important data regarding the use of extracorporeal membrane oxygenation (ECMO) to support cardiopulmonary resuscitation (CPR) by analyzing multiinstitutional data (295 patients) from the Extracorporeal Life Support Organization Registry. They showed that pre-ECMO factors (eg, arterial blood partial pressure of oxygen) are important for outcomes, but also the need for renal replacement therapy during ECMO. In addition, convincing data was presented regarding the complications that frequently occur during ECMO, including metabolic, cardiac, gastrointestinal, pulmonary, and renal complications.
During recent years microcirculation has attracted increased attention since imaging techniques began to noninvasively visualize the smallest vessels with new intra-vital microscopes, and the prognostic importance has been recognized for the prognosis of critically ill patients [2]. The microcirculation provides gas and nutrient exchange, and organ failures are strongly associated with microcirculatory changes.
Therefore we investigated the flow in the smallest vessel as microvascular flow index (MFI), which can monitor microflow changes during ECMO therapy [3]. Sublingual MFI was evaluated as previously described [4] using a side-stream dark field intra-vital microscope in 6 patients with emergently implanted ECMO (4 patients [Medtronic, Minneapolis, MN]; 2 patients [Lifebridge, Munich, Germany]; 4 men, 2 women; four resuscitations, with two during emergency cardiac intervention). The recorded video sequences were later analyzed in a semi-quantitative way (0 = no flow, 1 = intermittent flow, 2 = sluggish flow, 3 = continuous flow) separately for each vessel category (small, 10 to 25 µm; medium, 26 to 50 µm; large, 51 to 100 µm). Although mean arterial pressure was optimal (69.5 ± 5.5 mm Hg), the flow in the smallest vessels was not completely restored (MFI small, 2.61 ± 0.29; MFI medium, 2.53 ± 0.58; MFI large, 2.70 ± 0.44). Despite re-storing macrocirculation, the high frequency of organ failure may result from suboptimal microcirculation.
We believe that our therapeutic efforts should address the microcirculation. At first, we have to measure microcirculatory changes during ECMO. Second, we have to improve our treatment strategy by appropriate adaptation of ECMO or the infusion rates of catecholamines, fluids, or other drugs, or a combination of these, to restore physiologic conditions of microcirculation.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
R. R. Thiagarajan, T. V. Brogan, and S. L. Bratton Reply. Ann. Thorac. Surg., January 1, 2010; 89(1): 346 - 346. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |